Financials
Financial year 2025
Gross margin
€ 3.6 million
▼ 23% vs 2024
Profit
Healthy€ 417,943
▼ 69% vs 2024
Debts
Low€ 1.2 million
▲ 47% vs 2024
LABO VOOR KLINISCHE BIOLOGIE from Evergem, company number BE0451023967, closed financial year 2025 with a result of € 417,943 after tax. For that financial year LABO VOOR KLINISCHE BIOLOGIE recorded a gross margin of € 3.6 million and equity of € 8.6 million. Compared with financial year 2024, the result moved from € 1.3 million to € 417,943. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
What happened at LABO VOOR KLINISCHE BIOLOGIE?
What happened at LABO VOOR KLINISCHE BIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 417,943 (▼ 69% vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- Emiel Van Camp became a director. NBB
- Post Verba Verbera NV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 3.1 million profit in 2021 to € 417,943 profit in 2025.
Paid € 2.2 million in corporate taxes since 2021.
Best year ever: 2021, with € 3.1 million profit.
On average € 124,300 of value added per employee in 2025.
A new publication or filing at LABO VOOR KLINISCHE BIOLOGIE? We notify you, reason included.
Follow LABO VOOR KLINISCHE BIOLOGIENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind LABO VOOR KLINISCHE BIOLOGIE are Emiel Van Camp and Post Verba Verbera NV. The same people are also behind LABORATORIUM M. NUYTINCK, QUOD BONUM, FELIX FAUSTUMQUE SIT, POST VERBA VERBERA, ANABIOTEC and OHMX.bio.
Directors
According to the 2025 annual accounts
Emiel Van Camp
Director
Also active at: LABORATORIUM M. NUYTINCK, QUOD BONUM, FELIX FAUSTUMQUE SIT, POST VERBA VERBERA +3 more
since 2018
Director · represented by Margareta Nuytinck
Also active at: LABORATORIUM M. NUYTINCK, ANABIOTEC, OHMX.bio +2 more
since 2012
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Legeweg 176
8200 Brugge
Active since 14 November 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
LABORATORIUM M. NUYTINCK same network
€ 24.5 million revenue · 2025
POST VERBA VERBERA same network
€ 4.5 million revenue · 2025
ANABIOTEC same network
€ 9 million gross margin · 2025
Group Nuytinck
OHMX.bio same network
€ 1.7 million gross margin · 2025
+5 more
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
LEVEL27-AS * Please direct all complaints to support@level27.be *, BE
Website info
Features
Security
Network
Details
- Company number
- 0451.023.967
- VAT number
- BE 0451.023.967
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- LABO VOOR KLINISCHE BIOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 September 1993
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- nuytinck.be 092536030
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria